BioKier, Inc.
Biotechnology company · Chapel Hill, North Carolina, United States
BioKier, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2008. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.2 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $230,000 sold in a notice filed in 2014.
BioKier at a glance
What does BioKier do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $5.2 million in total (2015 to 2024). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $230,000 sold (2014).
Frequently asked questions about BioKier
Where is BioKier headquartered?
BioKier, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does BioKier do?
BioKier, Inc. is a biotechnology company.
When was BioKier founded?
The earliest incorporation on record for BioKier, Inc. is in 2008, according to public company registers.
Similar companies
- Redbud Labs, Inc.Chapel Hill, North Carolina, United States
- Clinical Tools, IncChapel Hill, North Carolina, United States
- OncoTrap, Inc.Chapel Hill, North Carolina, United States
- Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
- Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Theravida, Inc.Chapel Hill, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences